BACK
TO MAIN
PAGE

Influenza

General Information

Influenza virus types A and B are both common causes of acute respiratory illnesses, although influenza A viruses are the principal cause of large epidemics, as well as pandemics. Recorded since the middle of the 18th century, new influenza A subtypes have caused global pandemics at unpredictable intervals.

Severe morbidity and mortality are more common among elderly people and in specific high-risk groups.

Influenza viruses undergo frequent changes in their surface antigens. Immunity resulting from infection by one influenza virus does not protect fully against antigenic or genetic variants of the same subtype (influenza A viruses) or type (influenza B viruses). As a consequence, influenza outbreaks occur every year. New influenza vaccines must be designed annually to match the circulating viruses which are expected to cause the next epidemic.

Show More

Epidemiology

Worldwide, these annual epidemics are estimated to result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths every year.

Hospitalisation and death occur mainly among high risk groups.

Vaccines
Pipeline

9
Vaccines in
the pipeline

Technology Platforms

  • Protein nanoparticles (1)
  • mRNA (6)
  • Whole-inactivated virus (2)

DEVELOPMENT PHASES

  • Phase I (5)
  • Phase II (2)
  • Phase III (2)

TRIAL POPULATION

    Paediatric (1)​
    Adults (5)​
    Adults + Older Adults (1)​
    Older Adults (2)​

Source: 
https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccines-quality/influenza
https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
[Accessed: November 2022]

Vaccines Europe Pipeline Review

Download our pipeline review